Company Filing History:
Years Active: 2020
Title: Keyang Yang: Innovator in Biosensor Technology
Introduction
Keyang Yang is a prominent inventor based in Piscataway, NJ (US). He has made significant contributions to the field of biosensor technology, particularly through his innovative work involving magnesium zinc oxide nanostructures. His research focuses on developing advanced monitoring systems for cell populations, which have important implications in medical diagnostics and treatment.
Latest Patents
Keyang Yang holds a patent for a "Magnesium zinc oxide nanostructure modified biosensor and monitoring of response of cell population to an agent using the same." This invention utilizes a magnesium zinc oxide (MZO) nanostructure modified quartz crystal microbalance (MZO-QCM). It combines the unique sensing ability and biocompatibility of MZO-based nanostructures with the dynamic impedance spectrum capability of bulk acoustic wave (BAW) devices, including QCM. This technology enables real-time, noninvasive, and label-free monitoring of cell populations, specifically targeting the susceptibility and resistance of bacterial and fungal strains, as well as cancer cells, to various drugs.
Career Highlights
Keyang Yang is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research in biosensor technology. His work has garnered attention for its potential to revolutionize how we monitor and treat various diseases. With a focus on practical applications, Yang's innovations are paving the way for more effective medical interventions.
Collaborations
Keyang Yang has collaborated with notable colleagues, including Yicheng Lu and Pavel Ivanoff Reyes. These partnerships enhance the research and development of biosensor technologies, contributing to a collaborative environment that fosters innovation.
Conclusion
Keyang Yang's contributions to biosensor technology exemplify the impact of innovative thinking in the medical field. His patented work on magnesium zinc oxide nanostructures represents a significant advancement in real-time cell monitoring. As he continues his research at Rutgers, the potential for further breakthroughs in medical diagnostics remains promising.